Growth Equity Opportunities Fund, Llc - Net Worth and Insider Trading
Growth Equity Opportunities Fund, Llc Net Worth
The estimated net worth of Growth Equity Opportunities Fund, Llc is at least $0 dollars as of 2024-06-25. Growth Equity Opportunities Fund, Llc is the 10% Owner of ARYx Therapeutics Inc and owns about 0 shares of ARYx Therapeutics Inc (ARYX) stock worth over $0. Details can be seen in Growth Equity Opportunities Fund, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Growth Equity Opportunities Fund, Llc has not made any transactions after 2011-03-10 and currently still holds the listed stock(s).
Transaction Summary of Growth Equity Opportunities Fund, Llc
Growth Equity Opportunities Fund, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Growth Equity Opportunities Fund, Llc owns 3 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , ARYx Therapeutics Inc (ARYX) , and Viracta Therapeutics Inc (VIRX) .
Insider Ownership Summary of Growth Equity Opportunities Fund, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNSS | Sunesis Pharmaceuticals Inc | 2014-08-27 | 10 percent owner |
| ARYX | ARYx Therapeutics Inc | 2011-03-10 | 10 percent owner |
| VIRX | Viracta Therapeutics Inc | 2009-04-03 | 10 percent owner |
Growth Equity Opportunities Fund, Llc Latest Holdings Summary
Growth Equity Opportunities Fund, Llc currently owns a total of 1 stock. Growth Equity Opportunities Fund, Llc owns 0 shares of ARYx Therapeutics Inc (ARYX) as of March 10, 2011, with a value of $0.
Latest Holdings of Growth Equity Opportunities Fund, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARYX | ARYx Therapeutics Inc | 2011-03-10 | 0 | 0.00 | 0 |
Holding Weightings of Growth Equity Opportunities Fund, Llc
Growth Equity Opportunities Fund, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Growth Equity Opportunities Fund, Llc has made a total of 0 transactions in ARYx Therapeutics Inc (ARYX) over the past 5 years. The most-recent trade in ARYx Therapeutics Inc is the sale of 4,469,274 shares on March 10, 2011, which brought Growth Equity Opportunities Fund, Llc around $312,849.
Insider Trading History of Growth Equity Opportunities Fund, Llc
- 1
Growth Equity Opportunities Fund, Llc Trading Performance
Growth Equity Opportunities Fund, Llc Ownership Network
Growth Equity Opportunities Fund, Llc Owned Company Details
What does Sunesis Pharmaceuticals Inc do?
Who are the key executives at Sunesis Pharmaceuticals Inc?
Growth Equity Opportunities Fund, Llc is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks Judith A. Fox .
Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sunesis Pharmaceuticals Inc Insider Transactions
Growth Equity Opportunities Fund, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Growth Equity Opportunities Fund, Llc. You might contact Growth Equity Opportunities Fund, Llc via mailing address: 1119 St. Paul Street, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
